BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Zhong L, Zhao Y. Oncolytic adenovirus: A tool for reversing the tumor microenvironment and promoting cancer treatment (Review). Oncol Rep 2021;45:49. [PMID: 33760203 DOI: 10.3892/or.2021.8000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Ailia MJ, Yoo SY. In Vivo Oncolytic Virotherapy in Murine Models of Hepatocellular Carcinoma: A Systematic Review. Vaccines (Basel) 2022;10:1541. [PMID: 36146619 DOI: 10.3390/vaccines10091541] [Reference Citation Analysis]
2 Lin WW, Ou GY, Zhao WJ. Mutational profiling of low-grade gliomas identifies prognosis and immunotherapy-related biomarkers and tumour immune microenvironment characteristics. J Cell Mol Med 2021;25:10111-25. [PMID: 34597473 DOI: 10.1111/jcmm.16947] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Li M, Zhu Y, Bai B, Fang J, Yao W, Li Y, Li S, Li X, Jin N, Jiang R. Suppression effect of a dual cancer-specific oncolytic adenovirus on luciferase-labeled human melanoma cells in vitro and in vivo. Cancer Biomark 2021;32:251-62. [PMID: 34459386 DOI: 10.3233/CBM-203150] [Reference Citation Analysis]